13.7 Vascular Hemodynamics, Starling Forces, Blood Components & Hemostasis

13.7 Vascular Hemodynamics, Starling Forces, Blood Components & Hemostasis

Vascular Hemodynamics and Fluid Physics

Ohm's Law Analogy for the Cardiovascular Circuit

The relationship between blood flow ($Q$ or $CO$), perfusion pressure gradient ($\Delta P$), and vascular resistance ($R$ or $TPR$) mirrors Ohm's Law of electrical circuits ($I = \Delta V / R$):

$$\Delta P = CO \times TPR \implies MAP - CVP = CO \times TPR$$

• Because Central Venous Pressure ($CVP$) in the right atrium is close to zero (0-4 mmHg): $$MAP \approx CO \times TPR$$
• Mean Arterial Pressure ($MAP$): The average pressure driving blood through systemic capillary beds across the cardiac cycle. Because the heart spends approximately twice as much time in diastole as in systole at resting heart rates (60-75 bpm), $MAP$ is a weighted average: $$MAP = DBP + \frac{1}{3}(SBP - DBP) = \frac{2}{3}DBP + \frac{1}{3}SBP$$ For a patient with blood pressure 120/80 mmHg: $MAP = 80 + \frac{1}{3}(40) = 93.3\text{ mmHg}$.

Poiseuille's Law and Arteriolar Resistance

Blood flow through non-turbulent cylindrical vessels is modeled by the Hagen-Poiseuille Equation:

$$R = \frac{8\eta L}{\pi r^4}$$

(where $\eta$ is blood viscosity, $L$ is vessel length, and $r$ is internal vessel radius).

• The Fourth Power Dependence ($R \propto 1/r^4$): Resistance is extraordinarily sensitive to vessel caliber. Reducing vessel radius by half increases its hydraulic resistance by a factor of $2^4 = 16$, reducing blood flow to 1/16th at a constant pressure gradient!
• Site of Regulation: The arterioles are densely wrapped with concentric layers of vascular smooth muscle and represent the primary site of adjustable Total Peripheral Resistance (TPR) and systemic blood pressure regulation. Sympathetic $\alpha_1$ receptor activation induces arteriolar vasoconstriction (decreased $r$, increased $TPR$, increased $MAP$), whereas $\beta_2$ receptors (in skeletal muscle beds) and local metabolic vasodilators (adenosine, high $CO_2$, low $O_2$, $H^+$, nitric oxide) induce vasodilation.

Continuity Equation and Velocity of Capillary Flow

By the Law of Conservation of Mass (Continuity Equation):

$$Q = v_1 A_1 = v_2 A_2 = \text{constant}$$

Flow velocity ($v$) is inversely proportional to the total aggregate cross-sectional area ($A_{total}$) of the vascular bed ($v = Q / A_{total}$). Although individual capillaries have microscopic cross-sections (5-8 micrometers), there are billions of capillaries in parallel, creating a massive total cross-sectional area (~2,500 square centimeters vs. ~3-5 square centimeters in the aorta). Consequently, blood velocity drops from ~30 cm/s in the aorta to a sluggish ~0.03 cm/s in capillaries, providing ample transit time for transcapillary gas and solute diffusion.

---

Capillary Starling Forces and Lymphatic Drainage

Transcapillary fluid movement between intravascular plasma and the interstitial space is dictated by four Starling forces:

$$\text{Net Filtration Pressure (NFP)} = \left[(P_c - P_{if}) - (\pi_c - \pi_{if})\right]$$

• Arteriolar End Dynamics: $NFP = (35 - 0) - (25 - 1) = +11\text{ mmHg}$ (Positive net pressure favors filtration out into tissues).
• Venular End Dynamics: $NFP = (15 - 0) - (25 - 1) = -9\text{ mmHg}$ (Negative net pressure favors reabsorption back into blood).
• Lymphatic Role: Filtration slightly exceeds reabsorption across the body, leaving an excess of ~2-3 liters/day of fluid in the interstitium. Blind-ended, highly permeable lymphatic capillaries collect this interstitial fluid (now termed lymph), filter it through lymph nodes, and return it to the venous circulation via the thoracic duct and right lymphatic duct at the junction of the internal jugular and subclavian veins. Pathological disruption (hypoalbuminemia from liver failure, elevated venous pressure from congestive heart failure, or lymphatic obstruction from filariasis or surgical resection) causes accumulation of interstitial fluid termed edema.

---

Blood Components and Formed Elements

Centrifuged whole blood fractionates into three discrete layers:

1. Plasma (55% of volume): Aqueous solution (90% water) containing electrolytes ($Na^+, Cl^-, K^+, HCO_3^-$), nutrients (glucose, amino acids, lipids), metabolic wastes (urea, creatinine), dissolved gases, and plasma proteins:
   • Albumin (60%): Synthesized exclusively by the liver; primary contributor to plasma oncotic pressure ($\pi_c$) and principal carrier for hydrophobic hormones, free fatty acids, and drugs.
   • Globulins (35%): $\alpha$- and $\beta$-globulins (transport proteins synthesized by liver) and $\gamma$-globulins (immunoglobulins / antibodies synthesized by plasma B cells).
   • Fibrinogen (4%): Soluble clotting factor substrate cleaved by thrombin during hemostasis.
2. Buffy Coat (<1% of volume): Thin leukocyte and platelet intermediate interface.
3. Erythrocytes (Hematocrit, 45% of volume): Packed red blood cell volume.

Erythrocyte Biology and Hemoglobin Kinetics

• Erythrocytes (RBCs): Anucleated, biconcave discs (7-8 micrometers diameter) specialized for gas transport. The biconcave architecture maximizes surface-area-to-volume ratio and grants extreme mechanical deformability, allowing RBCs to squeeze through 5 micrometer capillary lumina. During maturation (erythropoiesis in bone marrow stimulated by renal erythropoietin [EPO]), reticulocytes extrude their nucleus, mitochondria, and all organelles. Consequently, mature RBCs:
  • Generate ATP exclusively via anaerobic glycolysis (lactic acid fermentation).
  • Consume none of the oxygen they transport because they lack mitochondria and oxidative phosphorylation enzymes.
  • Possess a strict 120-day lifespan, after which aging, rigid RBCs fragment as they traverse the narrow endothelial cords of Billroth in the spleen. Splenic macrophages phagocytose them, recycling iron to the liver/marrow via transferrin and converting the protoporphyrin heme ring into biliverdin and unconjugated bilirubin.

---

Hemostasis: Primary and Secondary Cascades

Hemostasis arrests blood loss from a damaged vascular vessel through three tightly orchestrated stages:

1. Vascular Spasm: Endothelial disruption triggers immediate local reflex vasoconstriction of vascular smooth muscle, augmented by endothelin release, transiently blunting blood flow.
2. Primary Hemostasis (Platelet Plug Formation):
   • Adhesion: Endothelial disruption exposes subendothelial collagen. Von Willebrand Factor (vWF) binds collagen and tethers circulating platelets via their Glycoprotein Ib (GPIb) receptors.
   • Activation: Bound platelets undergo shape change, extending pseudopodia, and degranulate, releasing ADP and synthesizing Thromboxane $A_2$ ($TXA_2$, via COX-1). ADP and $TXA_2$ bind local platelet receptors, recruiting and activating additional platelets.
   • Aggregation: Activation induces a conformational shift in platelet Glycoprotein IIb/IIIa (GPIIb/IIIa) receptors, exposing binding pockets for fibrinogen. Fibrinogen acts as a dimeric molecular bridge linking adjacent platelets into a loose primary platelet plug.
3. Secondary Hemostasis (The Coagulation Cascade): A sequential enzymatic cascade of circulating zymogens converging on the common pathway to generate a stable, cross-linked fibrin mesh:
   • Extrinsic Pathway (Rapid, Initial): Subendothelial Tissue Factor (Factor III / Thromboplastin) is exposed to blood and complexes with Factor VIIa in the presence of $Ca^{2+}$ to activate Factor X to Factor Xa.
   • Intrinsic Pathway (Amplification): Contact activation of Factor XII $\to$ XIa $\to$ IXa. Factor IXa complexes with its cofactor Factor VIIIa on platelet phospholipid surfaces to activate Factor X to Factor Xa.
   • Common Pathway: Factor Xa complexes with cofactor Factor Va, $Ca^{2+}$, and phospholipids to form the prothrombinase complex. Prothrombinase cleaves Prothrombin (Factor II) into active Thrombin (Factor IIa).
   • Fibrin Polymerization & Cross-linking: Thrombin cleaves soluble Fibrinogen (Factor I) into insoluble Fibrin monomers (Factor Ia), which self-assemble into linear polymers. Thrombin also activates Factor XIII (Fibrin-Stabilizing Factor) to XIIIa, a transglutaminase that forms covalent isopeptide cross-links between fibrin strands, locking the primary platelet plug into a durable secondary hemostatic clot.
4. Fibrinolysis: Healing endothelial cells secrete tissue Plasminogen Activator (tPA), which converts plasminogen into plasmin. Plasmin digests the fibrin mesh into soluble fibrin degradation products, including D-dimers.